Trends in diabetes mellitus and related costs among hospital admissions in Switzerland, 2012–2020

Abstract Background In Switzerland, the prevalence of diabetes mellitus (DM) has increased in the general population, but little is known regarding DM-related hospitalizations and their impact on mortality and health costs. Hence, our objectives were to assess (1) the evolution of hospitalizations f...

Full description

Saved in:
Bibliographic Details
Main Authors: Hassan Abu Obaid, Pedro Marques-Vidal
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Online Access:https://doi.org/10.1186/s13098-025-01604-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571452984918016
author Hassan Abu Obaid
Pedro Marques-Vidal
author_facet Hassan Abu Obaid
Pedro Marques-Vidal
author_sort Hassan Abu Obaid
collection DOAJ
description Abstract Background In Switzerland, the prevalence of diabetes mellitus (DM) has increased in the general population, but little is known regarding DM-related hospitalizations and their impact on mortality and health costs. Hence, our objectives were to assess (1) the evolution of hospitalizations for DM as first diagnosis and as comorbidity; (2) the association of DM with ICU admission, length of stay (LOS), in-hospital mortality and costs. Methods Swiss hospital discharge data for period 2012–2020. Type 1 (T1DM), type 2 (T2DM) and other types (OTDM) of DM were considered. Results Between 2012 and 2020, the number of hospitalizations (% total) increased from 4204 (0.27) to 4980 (0.45) for T2DM, 539 (0.05) to 854 (0.08) for T1DM and 221 (0.02) to 381 (0.03) or OTDM. Hospitalizations with DM as comorbidity increased from 89,752 (8.6) to 128,700 (11.7) for T2DM, 2934 (0.29) to 3536 (0.32) or T1DM and 5774 (0.58) to 9143 (0.83) for OTDM. Compared to non-DM hospitalizations, all types of DM had a higher likelihood of lower limb amputation; hospitalizations for T1DM had a higher likelihood of ICU admission: odds ratio and 95% CI: 3.38 (3.19–3.59), while T2DM had higher LOS: 5.5 ± 1.0 vs. 5.1 ± 1.0 days, and all DM types had a lower odds of in-hospital mortality. Patients with any type of DM as comorbidity had a longer LOS than patients without. Total cost of DM rose from CHF 42 million in 2012 to almost 100 million in 2019 and decreased afterwards. Conclusion DM represents an increasing health and economic burden in Switzerland.
format Article
id doaj-art-77e565e0bb464ee98c483ab564f5595c
institution Kabale University
issn 1758-5996
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Diabetology & Metabolic Syndrome
spelling doaj-art-77e565e0bb464ee98c483ab564f5595c2025-02-02T12:35:09ZengBMCDiabetology & Metabolic Syndrome1758-59962025-01-011711810.1186/s13098-025-01604-zTrends in diabetes mellitus and related costs among hospital admissions in Switzerland, 2012–2020Hassan Abu Obaid0Pedro Marques-Vidal1School of Public Health, Tehran University of Medical Sciences TUMSDepartment of medicine, internal medicine, Lausanne University Hospital and University of LausanneAbstract Background In Switzerland, the prevalence of diabetes mellitus (DM) has increased in the general population, but little is known regarding DM-related hospitalizations and their impact on mortality and health costs. Hence, our objectives were to assess (1) the evolution of hospitalizations for DM as first diagnosis and as comorbidity; (2) the association of DM with ICU admission, length of stay (LOS), in-hospital mortality and costs. Methods Swiss hospital discharge data for period 2012–2020. Type 1 (T1DM), type 2 (T2DM) and other types (OTDM) of DM were considered. Results Between 2012 and 2020, the number of hospitalizations (% total) increased from 4204 (0.27) to 4980 (0.45) for T2DM, 539 (0.05) to 854 (0.08) for T1DM and 221 (0.02) to 381 (0.03) or OTDM. Hospitalizations with DM as comorbidity increased from 89,752 (8.6) to 128,700 (11.7) for T2DM, 2934 (0.29) to 3536 (0.32) or T1DM and 5774 (0.58) to 9143 (0.83) for OTDM. Compared to non-DM hospitalizations, all types of DM had a higher likelihood of lower limb amputation; hospitalizations for T1DM had a higher likelihood of ICU admission: odds ratio and 95% CI: 3.38 (3.19–3.59), while T2DM had higher LOS: 5.5 ± 1.0 vs. 5.1 ± 1.0 days, and all DM types had a lower odds of in-hospital mortality. Patients with any type of DM as comorbidity had a longer LOS than patients without. Total cost of DM rose from CHF 42 million in 2012 to almost 100 million in 2019 and decreased afterwards. Conclusion DM represents an increasing health and economic burden in Switzerland.https://doi.org/10.1186/s13098-025-01604-zDiabetes mellitusEpidemiologyTrendsHospitalizationCosts
spellingShingle Hassan Abu Obaid
Pedro Marques-Vidal
Trends in diabetes mellitus and related costs among hospital admissions in Switzerland, 2012–2020
Diabetology & Metabolic Syndrome
Diabetes mellitus
Epidemiology
Trends
Hospitalization
Costs
title Trends in diabetes mellitus and related costs among hospital admissions in Switzerland, 2012–2020
title_full Trends in diabetes mellitus and related costs among hospital admissions in Switzerland, 2012–2020
title_fullStr Trends in diabetes mellitus and related costs among hospital admissions in Switzerland, 2012–2020
title_full_unstemmed Trends in diabetes mellitus and related costs among hospital admissions in Switzerland, 2012–2020
title_short Trends in diabetes mellitus and related costs among hospital admissions in Switzerland, 2012–2020
title_sort trends in diabetes mellitus and related costs among hospital admissions in switzerland 2012 2020
topic Diabetes mellitus
Epidemiology
Trends
Hospitalization
Costs
url https://doi.org/10.1186/s13098-025-01604-z
work_keys_str_mv AT hassanabuobaid trendsindiabetesmellitusandrelatedcostsamonghospitaladmissionsinswitzerland20122020
AT pedromarquesvidal trendsindiabetesmellitusandrelatedcostsamonghospitaladmissionsinswitzerland20122020